Marken
Marken, a leading global provider of supply chain solutions for the pharmaceutical and life sciences industries, is headquartered in the United States. Founded in 1980, Marken has established itself as a trusted partner in clinical trial logistics, offering specialised services that include temperature-controlled transportation, clinical trial supply management, and home healthcare solutions. With a strong operational presence across North America, Europe, and Asia, Marken is renowned for its commitment to quality and compliance, ensuring the safe and efficient delivery of critical medical products. The company’s unique approach combines advanced technology with a deep understanding of regulatory requirements, positioning it as a market leader in the logistics sector. Notable achievements include its extensive network of depots and a robust track record in supporting complex clinical trials, making Marken an indispensable ally in the advancement of global healthcare.
DitchCarbon Score
How does Marken's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Marken's score of 36 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Marken's reported carbon emissions
In 2022, Marken reported total carbon emissions of approximately 81,611,000 kg CO2e, which included 2,358,000 kg CO2e from Scope 1, 8,382,000 kg CO2e from Scope 2, and a significant 70,871,000 kg CO2e from Scope 3 emissions. The company has not disclosed emissions data for 2023, but it has set ambitious climate commitments, aiming for net zero carbon emissions by 2050 across all scopes. This commitment aligns with the Paris Agreement and is part of a long-term reduction pathway initiated in 2023. Marken's emissions data is cascaded from its parent company, Marken Limited, which is classified under the healthcare providers and services sector. The company is also committed to reducing its Scope 1 and Scope 2 emissions in line with its net zero target. Additionally, Marken's near-term targets are classified as "Committed" under the Science Based Targets initiative (SBTi), indicating a structured approach to addressing its carbon footprint. Overall, Marken's climate strategy reflects a proactive stance in tackling climate change, with a focus on significant reductions in emissions across all scopes by 2050.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 2,358,000 |
| Scope 2 | 8,382,000 |
| Scope 3 | 70,871,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Marken is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
